Cargando…
Harnessing the Benefits of Endogenous Hydrogen Sulfide to Reduce Cardiovascular Disease
Cardiovascular disease is the leading cause of death in the U.S. While various studies have shown the beneficial impact of exogenous hydrogen sulfide (H(2)S)-releasing drugs, few have demonstrated the influence of endogenous H(2)S production. Modulating the predominant enzymatic sources of H(2)S—cys...
Autores principales: | Casin, Kevin M., Calvert, John W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000539/ https://www.ncbi.nlm.nih.gov/pubmed/33806545 http://dx.doi.org/10.3390/antiox10030383 |
Ejemplares similares
-
The Drug Developments of Hydrogen Sulfide on Cardiovascular Disease
por: Wen, Ya-Dan, et al.
Publicado: (2018) -
Hydrogen Sulfide as an Endogenous Modulator in Mitochondria and Mitochondria Dysfunction
por: Guo, Wei, et al.
Publicado: (2012) -
Imbalance of Endogenous Hydrogen Sulfide and Homocysteine in Chronic Obstructive Pulmonary Disease Combined with Cardiovascular Disease
por: He, Yanjing, et al.
Publicado: (2017) -
Role of Oxidative Stress and Reduced Endogenous Hydrogen Sulfide in Diabetic Nephropathy
por: Hussain Lodhi, Arslan, et al.
Publicado: (2021) -
Hydrogen Sulfide, an Endogenous Stimulator of Mitochondrial Function in Cancer Cells
por: Szabo, Csaba
Publicado: (2021)